Cellular Composite with HAPLN1 for Cartilage Model
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current models for studying articular cartilage, particularly those involving chondrocytes and osteoblasts, fail to accurately reflect in vivo conditions, leading to challenges in drug screening and understanding cartilage diseases like osteoarthritis.
Innovation Solution
A cellular composite is developed, comprising a 3D cell growth material with distributed chondrocytes and a surface coated with osteoblasts, where the chondrocytes are differentiated in the presence of HAPLN1 protein to produce aggrecan, mimicking healthy or diseased articular cartilage.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If MSCs are used for chondrogenic differentiation in 3D hydrogels, then cartilage repair potential is improved, but hypertrophic phenotype and undesired calcification occur
Solution Approach 1:
The invention changes the biochemical parameters of the culture system by introducing HAPLN1 protein at specific concentrations (e.g., 100 ng/mL) during chondrogenic differentiation. This parameter modification prevents hypertrophic transformation of chondrocytes while maintaining their cartilage-forming capability, thereby eliminating undesired calcification while preserving repair potential
Solution Approach 2:
HAPLN1 protein serves as an intermediary substance that mediates between MSCs and the extracellular matrix environment. It binds to hyaluronic acid and proteoglycans to create a controlled microenvironment that guides chondrogenic differentiation without triggering hypertrophic changes, thus preventing calcification while enabling reliable cartilage repair
2Device complexity
If existing 3D models use single cell types or simplified structures, then model simplicity is improved, but in vivo condition accuracy deteriorates
Solution Approach 1:
The invention creates a composite 3D model system combining multiple cell types (chondrocytes and osteoblasts) within a biomimetic extracellular matrix composed of hyaluronic acid, proteoglycans, and HAPLN1 protein. This composite structure accurately replicates the complexity of native articular cartilage while maintaining model usability for drug screening and disease study
3Ease of manufacture
If chondrocytes are cultured without HAPLN1 protein, then culture simplicity is improved, but aggrecan production and cartilage matrix formation deteriorate
Solution Approach 1:
HAPLN1 protein is introduced during the early stages of chondrogenic differentiation (preliminary action) to establish proper matrix assembly pathways. This preliminary presence of HAPLN1 ensures optimal aggrecan production and cartilage matrix formation throughout the culture period, while the protein can be added to standard culture protocols without significantly complicating the manufacturing process
Data Source
AI summary
The present invention relates to a cellular composite comprising a 3D (three dimensional) cell growth material within which a population of chondrocytes is distributed, and which has a surface that is coated with a population of osteoblasts. The invention also relates to a method of producing said cellular composite and composites produced by the method of the invention. Further the invention relates to an in vitro model for studying healthy or diseased articular cartilage, as well as uses of the composite as an in vitro model. Finally, the invention relates to a method of screening an agent for the treatment or prevention of articular cartilage disease.